Relafen Naproxium 750, viewed examined from a biochemical molecular pharmacy perspective, represents a compelling or interesting illustration of NSAID pain reliever action. Its mechanism or mode involves primarily substantially inhibiting cyclooxygenase enzymes, specifically COX-2, thereby reducing diminishing the production of prostaglandins – k